LncRNA levels are strongly associated with aberrant gene expression that may drive cancer development and progression [9], such as HOTAIR in non-small cell lung cancer (NSCLC) [10], PRNCR1 (also known as PCAT8) and PCGEM1 in prostate cancer [11], and MEG3 in cervical cancer and meningiomas [12, 13]. This evidence concerns the gene PRNCR1 and prostate carcinoma.